Cargando…
Exosomal microRNAs in non-small cell lung cancer
Lung cancer is one of the highest incidence cancer types worldwide and one with the lowest 5-year survival rate of all cancer types. Despite recent insights into lung cancer pathobiology, including novel biomarker-targeted therapies and immunotherapies, most of lung patients are diagnosed at late st...
Autores principales: | Duréndez-Sáez, Elena, Torres-Martinez, Susana, Calabuig-Fariñas, Silvia, Meri-Abad, Marina, Ferrero-Gimeno, Macarena, Camps, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798604/ https://www.ncbi.nlm.nih.gov/pubmed/35116621 http://dx.doi.org/10.21037/tcr-20-2815 |
Ejemplares similares
-
Clinic and therapeutic potential of non-coding RNAs in cancer
por: Castellano, Joan Josep, et al.
Publicado: (2021) -
Vitamin D modulation and microRNAs in gastric cancer: prognostic and therapeutic role
por: Gallardo Martin, Elena, et al.
Publicado: (2021) -
MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies
por: Vahabi, Mahrou, et al.
Publicado: (2021) -
Long non-coding RNAs regulating multiple proliferative pathways in cancer cell
por: De Martino, Marco, et al.
Publicado: (2021) -
MicroRNAs and Xenobiotic Toxicity: An Overview
por: Balasubramanian, Satheeswaran, et al.
Publicado: (2020)